share_log

平潭发展(000592):种苗培育业务新拓展 医疗布局稳步推进

Pingtan Development (000592): new Development of Seedling cultivation Business and steady Progress of Medical layout

興業證券 ·  Jun 24, 2015 00:00  · Researches

Event: the company announced that it signed a cooperation framework agreement with Southern Pharmaceutical and Fujian Forestry Research Institute, and the three parties will give full play to their respective advantages and cooperate effectively. strive to overcome the technical bottleneck of high taxol alkane yew breeding, resource efficient cultivation and industrial development.

Comments: the medical value of yew is very high. Taxus is recognized as a natural rare anticancer plant on the verge of extinction in the world. The bark of Taxus chinensis has an anticancer substance-paclitaxel, which was designated as a first-class rare and endangered plant in China in 1994. The advantages of the three parties complement each other, and this cooperation opens up a new direction for the company to develop its seedling cultivation business. The base resources and industrial production advantages of Nanfang Pharmaceutical and the company, together with the advantages of science and technology and human resources of the Research Institute, effectively ensure the smooth implementation of the cooperation project. In the future, the company will build a new and efficient medicinal yew GAP planting base based on the advantages of woodland resources in Mingxi County and southern pharmaceutical research, production and marketing, so as to provide raw materials for the production of taxane products for Southern Pharmaceutical.

Profit forecast and investment rating: at present, the Pingtan government is applying for a free port, and the free port will bring more policy benefits and relaxation. the liberalization of the relevant policies by the free port will bring infinite imagination to the long-term discovery of the whole Pingtan Island; the company is the only listing platform in Pingtan Island, with scarcity. The chairman has many years of political experience and extensive connections, and has signed a comprehensive strategic cooperation agreement with the Pingtan Management Committee, and is expected to become a comprehensive developer in Pingtan Comprehensive Experimental Zone. This cooperation is a beneficial attempt for the company to expand its business of cultivating new seedlings and is beneficial to long-term development; it is estimated that the EPS of the company in 15-17 years will be 0.38 EPS 0.56 pounds respectively, maintaining the "overweight" rating.

Risk hint: the overall development of Pingtan experimental area is not as expected, and the progress of the company's project is not as expected.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment